Display options
Cite
Sawa T. The molecular mechanism of acute lung injury caused by Pseudomonas aeruginosa: from bacterial pathogenesis to host response. J Intensive Care. 2014;2(1):10doi: 10.1186/2052-0492-2-10.
Sawa, T. (2014). The molecular mechanism of acute lung injury caused by Pseudomonas aeruginosa: from bacterial pathogenesis to host response. Journal of intensive care, 2(1), 10. https://doi.org/10.1186/2052-0492-2-10
Sawa, Teiji. "The molecular mechanism of acute lung injury caused by Pseudomonas aeruginosa: from bacterial pathogenesis to host response." Journal of intensive care vol. 2,1 (2014): 10. doi: https://doi.org/10.1186/2052-0492-2-10
Sawa T. The molecular mechanism of acute lung injury caused by Pseudomonas aeruginosa: from bacterial pathogenesis to host response. J Intensive Care. 2014 Feb 18;2(1):10. doi: 10.1186/2052-0492-2-10. eCollection 2014. PMID: 25520826; PMCID: PMC4267601.
Copy Download .nbib Format: NLM
Share it on

J Intensive Care. 2014 Feb 18;2(1):10. doi: 10.1186/2052-0492-2-10. eCollection 2014.

The molecular mechanism of acute lung injury caused by Pseudomonas aeruginosa: from bacterial pathogenesis to host response.

Journal of intensive care

Teiji Sawa

Affiliations

  1. Department of Anesthesiology, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Kamigyo, Kyoto, 602-8566 Japan.

PMID: 25520826 PMCID: PMC4267601 DOI: 10.1186/2052-0492-2-10

Abstract

Pseudomonas aeruginosa is the most common gram-negative pathogen causing pneumonia in immunocompromised patients. Acute lung injury induced by bacterial exoproducts is associated with a poor outcome in P. aeruginosa pneumonia. The major pathogenic toxins among the exoproducts of P. aeruginosa and the mechanism by which they cause acute lung injury have been investigated: exoenzyme S and co-regulated toxins were found to contribute to acute lung injury. P. aeruginosa secretes these toxins through the recently defined type III secretion system (TTSS), by which gram-negative bacteria directly translocate toxins into the cytosol of target eukaryotic cells. TTSS comprises the secretion apparatus (termed the injectisome), translocators, secreted toxins, and regulatory components. In the P. aeruginosa genome, a pathogenic gene cluster, the exoenzyme S regulon, encodes genes underlying the regulation, secretion, and translocation of TTSS. Four type III secretory toxins, namely ExoS, ExoT, ExoU, and ExoY, have been identified in P. aeruginosa. ExoS is a 49-kDa form of exoenzyme S, a bifunctional toxin that exerts ADP-ribosyltransferase and GTPase-activating protein (GAP) activity to disrupt endocytosis, the actin cytoskeleton, and cell proliferation. ExoT, a 53-kDa form of exoenzyme S with 75% sequence homology to ExoS, also exerts GAP activity to interfere with cell morphology and motility. ExoY is a nucleotidal cyclase that increases the intracellular levels of cyclic adenosine and guanosine monophosphates, resulting in edema formation. ExoU, which exhibits phospholipase A2 activity activated by host cell ubiquitination after translocation, is a major pathogenic cytotoxin that causes alveolar epithelial injury and macrophage necrosis. Approximately 20% of clinical isolates also secrete ExoU, a gene encoded within an insertional pathogenic gene cluster named P. aeruginosa pathogenicity island-2. The ExoU secretory phenotype is associated with a poor clinical outcome in P. aeruginosa pneumonia. Blockade of translocation by TTSS or inhibition of the enzymatic activity of translocated toxins has the potential to decrease acute lung injury and improve clinical outcome.

Keywords: Acute lung injury; ExoU; Pneumonia; Pseudomonas aeruginosa; Type III secretion system

References

  1. J Biol Chem. 2012 Jul 20;287(30):25407-18 - PubMed
  2. EMBO J. 2000 Aug 1;19(15):3876-87 - PubMed
  3. J Appl Physiol (1985). 1993 Oct;75(4):1661-9 - PubMed
  4. Crit Care Med. 2004 Nov;32(11):2293-9 - PubMed
  5. Pediatr Pulmonol. 2014 Jul;49(7):650-8 - PubMed
  6. Infect Immun. 1993 Jan;61(1):71-80 - PubMed
  7. Cell Microbiol. 2001 Apr;3(4):223-36 - PubMed
  8. Trends Microbiol. 2000 May;8(5):214-20 - PubMed
  9. BMC Infect Dis. 2013 Nov 27;13:561 - PubMed
  10. Infect Immun. 1984 Aug;45(2):470-4 - PubMed
  11. Circ Res. 2004 Jul 23;95(2):196-203 - PubMed
  12. Trends Microbiol. 1997 Apr;5(4):148-56 - PubMed
  13. Semin Respir Crit Care Med. 2009 Feb;30(1):61-6 - PubMed
  14. Mol Microbiol. 1997 Aug;25(3):547-57 - PubMed
  15. Arch Intern Med. 1996 Oct 14;156(18):2121-6 - PubMed
  16. J Clin Invest. 1988 Oct;82(4):1422-9 - PubMed
  17. Int J Infect Dis. 2008 Sep;12(5):505-12 - PubMed
  18. Proc Natl Acad Sci U S A. 1993 Mar 15;90(6):2320-4 - PubMed
  19. EMBO J. 2003 Oct 1;22(19):4957-67 - PubMed
  20. Science. 1999 May 21;284(5418):1322-8 - PubMed
  21. Am J Physiol. 1994 Nov;267(5 Pt 1):L551-6 - PubMed
  22. Infect Immun. 1997 Feb;65(2):579-86 - PubMed
  23. J Biol Chem. 1991 Apr 5;266(10):6438-46 - PubMed
  24. Int J Med Microbiol. 2000 Oct;290(4-5):381-7 - PubMed
  25. Crit Care Med. 2012 Aug;40(8):2320-6 - PubMed
  26. FEMS Microbiol Lett. 2005 Sep 1;250(1):71-6 - PubMed
  27. Biochem Biophys Res Commun. 2004 Apr 2;316(2):323-31 - PubMed
  28. Mol Microbiol. 1997 Nov;26(4):621-9 - PubMed
  29. J Bacteriol. 1997 Mar;179(5):1609-13 - PubMed
  30. Proc Natl Acad Sci U S A. 1978 Jul;75(7):3211-5 - PubMed
  31. Infect Immun. 1989 Mar;57(3):996-8 - PubMed
  32. Infect Immun. 2010 Apr;78(4):1447-56 - PubMed
  33. Nature. 2000 Aug 31;406(6799):959-64 - PubMed
  34. J Clin Invest. 1999 Sep;104(6):743-50 - PubMed
  35. J Biol Chem. 1989 May 25;264(15):9004-8 - PubMed
  36. Infect Immun. 2000 Jan;68(1):403-6 - PubMed
  37. JAMA. 1995 Sep 27;274(12):968-74 - PubMed
  38. Infect Immun. 1979 Jun;24(3):837-42 - PubMed
  39. J Biol Chem. 1994 Apr 8;269(14):10431-7 - PubMed
  40. J Chemother. 2008 Dec;20(6):714-20 - PubMed
  41. Microbiol Mol Biol Rev. 1998 Jun;62(2):379-433 - PubMed
  42. J Clin Invest. 1991 Sep;88(3):864-75 - PubMed
  43. Intensive Care Med. 2013 Apr;39(4):682-92 - PubMed
  44. J Clin Invest. 1993 Sep;92(3):1221-8 - PubMed
  45. Infect Immun. 1994 Feb;62(2):554-63 - PubMed
  46. Nat Med. 1999 Apr;5(4):392-8 - PubMed
  47. J Biol Chem. 1999 Dec 17;274(51):36369-72 - PubMed
  48. J Immune Based Ther Vaccines. 2003 Aug 13;1(1):2 - PubMed
  49. Infect Immun. 2003 Apr;71(4):2230-3 - PubMed
  50. Mol Microbiol. 2011 Dec;82(6):1454-67 - PubMed
  51. J Bacteriol. 1996 Mar;178(5):1412-9 - PubMed
  52. J Bacteriol. 1995 Aug;177(15):4427-36 - PubMed
  53. J Infect Dis. 2002 Jul 1;186(1):64-73 - PubMed
  54. Infect Immun. 2009 Mar;77(3):1083-90 - PubMed
  55. Proc Natl Acad Sci U S A. 1998 Nov 10;95(23):13899-904 - PubMed
  56. Infect Immun. 1993 Jan;61(1):307-13 - PubMed
  57. Crit Care Med. 2012 Apr;40(4):1157-63 - PubMed
  58. J Biol Chem. 2013 Sep 13;288(37):26741-52 - PubMed
  59. Antibiot Chemother (1971). 1985;36:40-8 - PubMed
  60. J Immunol. 2001 Nov 15;167(10):5880-6 - PubMed
  61. Infect Immun. 1981 Oct;34(1):147-53 - PubMed
  62. Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11638-43 - PubMed
  63. Infect Immun. 2002 Apr;70(4):2198-205 - PubMed
  64. Infect Immun. 2000 Dec;68(12):7100-13 - PubMed
  65. Mol Microbiol. 1999 Jun;32(5):961-76 - PubMed
  66. Infect Immun. 2001 May;69(5):3516-8 - PubMed
  67. Infect Immun. 2002 Jan;70(1):360-7 - PubMed
  68. Infect Immun. 2000 Oct;68(10):6066-8 - PubMed
  69. J Bacteriol. 1998 Dec;180(23):6224-31 - PubMed
  70. J Bacteriol. 1991 Oct;173(20):6460-8 - PubMed
  71. J Immunol. 1984 Oct;133(4):2226-30 - PubMed
  72. Diagn Microbiol Infect Dis. 2014 Mar;78(3):271-6 - PubMed
  73. Infect Immun. 2000 Jul;68(7):3998-4004 - PubMed
  74. Can J Microbiol. 1985 Apr;31(4):387-92 - PubMed
  75. Semin Respir Crit Care Med. 2009 Feb;30(1):10-5 - PubMed
  76. Mol Microbiol. 1998 Feb;27(4):807-18 - PubMed
  77. Infect Control Hosp Epidemiol. 2013 Jul;34(7):657-62 - PubMed
  78. FEMS Microbiol Lett. 1996 Jan 15;135(2-3):149-55 - PubMed
  79. Eur J Clin Microbiol. 1985 Apr;4(2):175-9 - PubMed
  80. J Infect Dis. 1985 Oct;152(4):716-21 - PubMed
  81. J Bacteriol. 1997 Nov;179(22):7165-8 - PubMed
  82. Antimicrob Agents Chemother. 2013 Aug;57(8):3969-75 - PubMed
  83. Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8484-9 - PubMed
  84. Mol Microbiol. 2001 Apr;40(2):294-305 - PubMed
  85. EMBO J. 2003 Jun 16;22(12 ):2959-69 - PubMed
  86. Crit Care Med. 2002 Mar;30(3):521-8 - PubMed
  87. Crit Care Med. 2014 Jan;42(1):48-56 - PubMed
  88. Mol Microbiol. 1996 Dec;22(5):991-1003 - PubMed
  89. Crit Care Med. 2014 Feb;42(2):303-12 - PubMed
  90. J Infect Dis. 2001 Jun 15;183(12):1767-74 - PubMed
  91. Proc Natl Acad Sci U S A. 2004 Feb 24;101(8):2530-5 - PubMed
  92. Science. 1998 Apr 24;280(5363):602-5 - PubMed
  93. EMBO J. 1996 Nov 1;15(21):5812-23 - PubMed
  94. Nature. 1956 Mar 3;177(4505):426-7 - PubMed
  95. Mol Microbiol. 1997 Mar;23(5):861-7 - PubMed
  96. Science. 2011 Mar 4;331(6021):1192-5 - PubMed
  97. Clin Microbiol Infect. 2008 Apr;14(4):330-6 - PubMed
  98. Mol Microbiol. 2001 Apr;40(2):271-83 - PubMed
  99. FEMS Microbiol Lett. 2001 Aug 21;202(2):157-64 - PubMed

Publication Types